Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Enadenotucirev |
| Synonyms | |
| Therapy Description |
Enadenotucirev is a conditionally-replicating group B adenovirus that has antitumor and immunomodulating activity (PMID: 26708004, PMID: 32532291). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Enadenotucirev | EnAd|ColoAd1|ColoAd-1 | Enadenotucirev is a conditionally-replicating group B adenovirus that has antitumor and immunomodulating activity (PMID: 26708004, PMID: 32532291). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|